Sign in

CIK 0001515673

  • Large accelerated filer

Ultragenyx Pharmaceutical Inc.

Sign in to watch
Ticker
RARE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
272546083
Phone
+1 415-483-8800
Business address
60 LEVERONI COURT, NOVATO, CA, 94949
  1. 4 Open-market sale President & CEO sold 47,853 shares at $33.52 ($1,604,033)
  2. 4 Grant or award Chief Financial Officer acquired 80,366 shares (grant or award)
  3. 3 Insider Initial Statement of Ownership
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Open-market sale SVP, Chief Accounting Officer sold 2,163 shares at an average $40.80 ($88,249)
  7. 4 Open-market sale EVP & Chief Commercial Officer sold 6,000 shares at $37.96 ($227,760)
  8. 4 Open-market sale SVP, Chief Accounting Officer sold 970 shares at an average $37.15 ($36,032)
  9. 4 Open-market sale Director sold 585 shares at $46.76 ($27,355)
  10. 4 Open-market sale EVP & Chief Commercial Officer sold 305 shares at $48.20 ($14,701)
  11. 4 Grant or award Director acquired 3,860 shares (grant or award)
  12. 4 Returned to the company Director returned 3,300 shares (to the company)
  13. 4 Open-market sale Director sold 1,485 shares at $51.65 ($76,700)
  14. 4 Grant or award Director acquired 3,860 shares (grant or award)
  15. 4 Grant or award Director acquired 3,860 shares (grant or award)
  16. 4 Grant or award Director acquired 3,860 shares (grant or award)
  17. 4 Grant or award Director acquired 3,860 shares (grant or award)
  18. 4 Open-market sale Pinion John Richard sold 2,012 shares at $50.00 ($100,600)
  19. 4 Exercise or conversion SVP, Chief Accounting Officer acquired 3,000 shares (option exercise)
  20. 4 Open-market sale EVP and Chief Legal Officer sold 4,378 shares at $45.00 ($197,010)

Page 6 of 32 · 627 filings